Amarin Corp Plc (AMRN)

[Hawk_Driver]

In laymen’s terms, the generic must be 80-125% equivalent to the brand, article below that spells that out in greater detail. The capsule could likely be engineered out of the problem. For example more epa in the generic capsule (slightly larger pill size). Generics can be innovative too, when they must. Especially when obtaining their bio-equivalency data:

https://www.pharmacytimes.com/contributor/timothy-o-shea/2016/06/debunking-a-common-pharmacy-myth-the-80-125-bioequivalence-rule

https://www.cbsnews.com/news/ranbaxy-whistleblower-reveals-how-he-exposed-massive-pharmaceutical-fraud/